Literature DB >> 19152817

Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis.

P V Ravindra1, Ashok K Tiwari, Barkha Ratta, Uttara Chaturvedi, Sudesh Kumar Palia, R S Chauhan.   

Abstract

The velogenic Newcastle disease virus (NDV) causes highly infectious and economically significant Newcastle disease (ND) in birds of various species. In cell culture NDV induces cytopathic effect (CPE) characterized by rounding, vacuolation, syncytia formation and cell death. Aside from cell to cell fusion caused by the F and HN glycoprotein of the virus molecular events leading to cell death are not known. In the current study, NDV-infected Vero cells, at 48 h p.i., showed nuclear condensation, cytoplasm blebbing, DNA fragmentation, and phosphatidylserine translocation to the cell surface. In addition, virus-infected cells demonstrated decreased DNA content and an increased Bax to Bcl-2 ratio, p53 level and caspase 3, 8, 9 expression compared to mock-infected cells. Based on these results, it was concluded that CPE in NDV-infected cells was caused by to the induction of apoptosis with the involvement of p53 and the Bax, dependent apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19152817     DOI: 10.1016/j.virusres.2008.12.008

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  27 in total

1.  Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma.

Authors:  Chun-Xiao Zhang; Long-Wei Ye; Ying Liu; Xiao-Ya Xu; Dan-Rui Li; Yan-Qing Yang; Lu-Lu Sun; Jie Yuan
Journal:  Tumour Biol       Date:  2015-04-16

2.  Characterization and expression of e2 glycoprotein of classical Swine Fever virus in a eukaryotic expression system.

Authors:  Barkha Ratta; Binita Nautiyal; P V Ravindra; Uttara Chaturvedi; Sudesh Kumar; P K Subudhi; Kantaraja Chindera; Sangeeta Tiwari; N N Barman; Ashok K Tiwari
Journal:  Indian J Virol       Date:  2010-09-03

Review 3.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

4.  The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo.

Authors:  Muhannad Alkassar; Barbara Gärtner; Klaus Roemer; Friedrich Graesser; Jean Rommelaere; Lars Kaestner; Isabelle Haeckel; Norbert Graf
Journal:  J Neurooncol       Date:  2011-05-24       Impact factor: 4.130

Review 5.  Hyperinflammation, apoptosis, and organ damage.

Authors:  Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

6.  Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models.

Authors:  Sara Cuadrado-Castano; Juan Ayllon; Mena Mansour; Janis de la Iglesia-Vicente; Stefan Jordan; Shashank Tripathi; Adolfo García-Sastre; Enrique Villar
Journal:  Mol Cancer Ther       Date:  2015-03-11       Impact factor: 6.261

Review 7.  The therapeutic effect of death: Newcastle disease virus and its antitumor potential.

Authors:  Sara Cuadrado-Castano; Maria T Sanchez-Aparicio; Adolfo García-Sastre; Enrique Villar
Journal:  Virus Res       Date:  2015-07-26       Impact factor: 3.303

8.  Characterization of nucleocapsid and matrix proteins of Newcastle disease virus in yeast.

Authors:  Sahaya Glingston; Jitika Rajpoot; Nayan Moni Deori; Rachayeeta Deb; Sachin Kumar; Shirisha Nagotu
Journal:  3 Biotech       Date:  2021-01-12       Impact factor: 2.406

Review 9.  Oncolytic viruses & their specific targeting to tumour cells.

Authors:  Prafull K Singh; Juwar Doley; G Ravi Kumar; A P Sahoo; Ashok K Tiwari
Journal:  Indian J Med Res       Date:  2012-10       Impact factor: 2.375

10.  The matrix (M) protein of Newcastle disease virus binds to human bax through its BH3 domain.

Authors:  Aidin Molouki; Yi-Te Hsu; Fatemeh Jahanshiri; Syahril Abdullah; Rozita Rosli; Khatijah Yusoff
Journal:  Virol J       Date:  2011-08-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.